Beta Capital launches new EUR 10 million Venture Capital Fund
Beta Innovation Fund aims to invest in portuguese early-stage high-tech start-ups
Beta Capital exits Heartgenetics after successful trade sale
ImpactLab Group enters the international market by acquiring 100% of HeartGenetics.
Heartgenetics signs commercial agreement with Agena Bioscience
HeartGenetics and Agena Bioscience signed a commercial partnership to bring affordable genetic testing to the market.
Beta Capital invests in Heartgenetics<br><br>
HeartGenetics is an innovative Portuguese biotech and bioinformatics company revolutionizing genetic testing.
Beta Capital exits Nonius Software after successful MBO
During the investment period, Nonius grew from a turnover of EUR 50k to EUR 7 million.
Nonius is market leader in South America
Operating in Brazil since 2011, with a branch in São Paulo, Nonius reaches a milestone of 300 customers in Latin America.